Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 173

Corporates get into Headspace for $93m series C

Chernin Group has returned for the meditation platform's $93m series C round, while Bennett Coleman & Co took part as a new investor.

Feb 13, 2020

Fenergo finishes up $80m round

ABN Amro Ventures added to a first tranche provided by DXC Technology, in a round that valued the financial services management platform at approximately $800m.

Feb 13, 2020

Hazelcast heightens series D to $50m

The computing platform developer has expanded a round backed by Capital One Growth Ventures from $21.5m to $50m.

Feb 13, 2020

Neo Career recruits corporates for new funding

Existing backers Mynavi and Link and Motivation were among the investors that backed a $41.4m round for the recruitment service provider.

Feb 13, 2020

SiriusXM gets serious with $75m SoundCloud investment

SoundCloud has received $75m from SiriusXM following an advertising partnership agreement with its Pandora subsidiary in 2019.

Feb 12, 2020

Carbon Relay receives Insight with $65m investment

The app optimisation platform developer has added $65m from Insight Partners to the Foxconn-backed series A it raised early last year.

Feb 12, 2020

Vezeeta eases into $40m series D

Gulf Capital led a round that boosted the Crescent Enterprises-backed medical booking platform's total funding to more than $63m.

Feb 12, 2020

Sonoma sends for Lyell in $40m series A

Sonoma Biotherapeutics has emerged from stealth with $40m to develop regulatory T-cell therapies for autoimmune and degenerative diseases.

Feb 10, 2020

Pepperfry cooks up $40m series F round

Pidilite Industries led a $40m round for Pepperfry that included existing backer Bertelsmann, lifting the furniture retailer's overall funding to $235m.

Feb 10, 2020

Sonoma sends for Lyell in $40m series A

Sonoma Biotherapeutics has emerged from stealth with $40m from investors including Lyell Immunopharma and is developing regulatory T-cell therapies for autoimmune and degenerative diseases.

Feb 10, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here